Survival outcomes in US patients with metastatic colorectal cancer (mCRC)

被引：1
|
作者：
Knopf, Kevin
Iqbal, Sheikh Usman
Thompson, Stephen F.
Malangone, Elisabetta
Gorritz-Kindu, Magdaliz
Stern, Lee
Sherman, Steven A.
Naoshy, Sarah
Wooten, Michael
Andria, Michael L.
机构：
[1] Pacif Hematol Oncol Associates, San Francisco, CA USA
[2] Sanofi, Cambridge, MA USA
[3] Sanofi, Bridgewater, NJ USA
[4] Analytica LA SER Int Inc, New York, NY USA
[5] Regeneron Pharmaceut, Dacula, GA USA
[6] Regeneron Pharmaceut Inc, Tarrytown, NY 10591 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2013年 / 31卷 / 04期
关键词：
D O I：
10.1200/jco.2013.31.4_suppl.559
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
559
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Survival for patients with resectable lung metastatic colorectal cancer (mCRC).
    Price, Timothy Jay
    Tomita, Yoko
    Beeke, Carol
    Padbury, Robert
    Townsend, Amanda Rose
    Maddern, Guy
    Roy, Amitesh
    Roder, David
    Karapetis, Christos Stelios
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (03)
  • [2] The cost of survival gains in metastatic colorectal cancer (mCRC) in the United States (US)
    Stillman, I. Ozer
    Chang, J.
    Whalen, J.
    Ambavane, A.
    Ngai, C.
    EUROPEAN JOURNAL OF CANCER, 2015, 51 : S181 - S181
  • [3] SURGICAL RESECTION OF LIVER METASTASES AND SURVIVAL OUTCOMES METASTATIC COLORECTAL CANCER (MCRC)
    Adda, Bounedjar
    Khelifa, Bendjebbar
    Haoui, Messaouda
    Kada, Boualaga
    El Mehdi, Si Ahmed
    ANNALS OF ONCOLOGY, 2014, 25
  • [4] Survival Outcomes With Use of Bevacizumab Beyond Progression (BBP) in Metastatic Colorectal Cancer (MCRC) Patients (Pts)
    Cartwright, T.
    Yu, E.
    Yim, Y.
    Hartnett, H.
    Chung, H.
    Halm, M.
    Forsyth, M.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S437 - S437
  • [5] Treatment patterns and outcomes in metastatic colorectal cancer (mCRC).
    Cartwright, Thomas H.
    Wen, Lonnie Kent
    Harrell, Robyn K.
    Fox, Patricia S.
    Espirito, Janet L.
    Wang, Ed
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (04)
  • [6] Cetuximab (Cet) clearance and survival in patients (pts) with metastatic colorectal cancer (mCRC)
    Jiang, Di Maria
    Sim, Hao-Wen
    Siu, Lillian L.
    Shapiro, Jeremy David
    Liu, Geoffrey
    Price, Timothy Jay
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (04)
  • [7] Cetuximab (Cet) clearance and survival in patients (pts) with metastatic colorectal cancer (mCRC).
    Jiang, Di Maria
    Sim, Hao-Wen
    Siu, Lillian L.
    Shapiro, Jeremy David
    Liu, Geoffrey
    Price, Timothy Jay
    Jonker, Derek J.
    Karapetis, Christos Stelios
    Strickland, Andrew
    Zhang, Wenjiang
    Jeffery, Mark
    Tu, Dongsheng
    Ng, Siobhan
    Sabesan, Sabe S.
    Shannon, Jenny
    Townsend, Amanda Rose
    Morgen, Eric
    Xu, Wei
    O'Callaghan, Christopher J.
    Chen, Eric Xueyu
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [8] Survival outcomes in US patients with metastatic colorectal cancer: A retrospective database analysis.
    Knopf, Kevin B.
    Iqbal, Sheikh Usman
    Thompson, Stephen F.
    Malangone, Elisabetta
    Gorritz-Kindu, Magdaliz
    Stern, Lee
    Sherman, Steven A.
    Naoshy, Sarah
    Wooten, Michael
    Andria, Michael L.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [9] Comorbidities in patients with metastatic colorectal cancer (mCRC)
    Fu, A. Z.
    Zhao, Z.
    Wang, P. F.
    Barber, B.
    Liu, G. G.
    EJC SUPPLEMENTS, 2009, 7 (02): : 339 - 339
  • [10] The cost of survival gain in metastatic colorectal cancer (mCRC) in Germany
    Whalen, J.
    Draexler, K.
    Stillman, I. Ozer
    Ambavane, A.
    Tamoschus, D.
    Chang, J.
    Ngai, C.
    EUROPEAN JOURNAL OF CANCER, 2015, 51 : S180 - S180
12345